NTHI Revenue

In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.

Revenue (ttm)

$39.99K

Revenue Growth

-51.82%

P/S Ratio

2,684.88

Revenue / Employee

$7,998

Employees

Market Cap

102.76M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	39.99K	-43.01K	-51.82%
Dec 31, 2024	83.00K	12.54K	17.79%
Dec 31, 2023	70.46K	50.46K	252.31%
Dec 31, 2022	20.00K	-	-
Dec 31, 2021	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Verrica Pharmaceuticals	35.58M
Pyxis Oncology	13.86M
Innate Pharma	10.57M
Cibus	3.64M
Cardiff Oncology	593.00K

Revenue Rankings

NTHI News

4 weeks ago - NeOnc Provides Business Update and Reports Q4 2025 Financial Results - GlobeNewsWire
6 weeks ago - NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewsWire
6 weeks ago - Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
2 months ago - NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - GlobeNewsWire
2 months ago - NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - GlobeNewsWire
3 months ago - NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management - GlobeNewsWire
3 months ago - Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
4 months ago - NeOnc Technologies Reports Updated Clinical Results - GlobeNewsWire

More News